Article info

Download PDFPDF
FDA’s reduced exposure marketing order for IQOS: why it is not a reliable global model

Authors

  1. Correspondence to Lauren Kass Lempert, Center for Tobacco Control Research & Education, UCSF, San Francisco, CA 94143, USA; Lauren.Lempert{at}ucsf.edu
View Full Text

Citation

Lempert LK, Bialous S, Glantz S
FDA’s reduced exposure marketing order for IQOS: why it is not a reliable global model

Publication history

  • Received October 20, 2020
  • Revised January 20, 2021
  • Accepted February 2, 2021
  • First published April 2, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.